Category: pharma & healthcare

The Remarkable Research Of CAR T Therapy [Part II]: B Cell Cancers

CAR T cell therapy is a recent innovation for people suffering from a range of B cell-derived cancers, including some forms of lymphoma and leukemia.

Self-Amplifying mRNA Vaccine Receives EUA Nod From Indian Regulators

India’s first home-grown Covid-19 mRNA vaccine uses self-amplifying RNA technology, can be stored in a conventional refrigerator instead of special freezers, and doesn’t require a needle. It marks a shift towards next-generation mRNA vaccines.

Lost In Translation In RCT Colonoscopy Study: Some Kind Of Colorectal Cancer Screening Is Essential To Lower Mortality Rates

The study may have people wondering whether they should have a colonoscopy. Much more problematically, the snippets people read or hear about the study in the news, in social media, and elsewhere, may have them questioning whether they should get scree…

Turning Very Old Drugs Like Makena Into Profits: Regulatory Reform Needed

There is nothing inherently wrong with profiting from old drugs. It depends on the drug in question, its efficacy and safety, and the context within which it was approved and priced in the market. Problems can arise if the newly branded drug has limite…

Supercharging mRNA Vaccines With Self-Amplifying RNA Technology

Messenger RNA (mRNA) vaccines have been crucial to containing and controlling the ongoing Covid-19 pandemic. Advances in self-amplifying RNA technology promise to make them even more cost effective and even quicker to produce.

Europe’s Emerging Covid-19 Wave Reminds Us That The Pandemic Isn’t Over Till It’s Over

During an interview on the television program 60 Minutes, President Biden asserted that “the pandemic is over.” For all intents and purposes, pre-pandemic life has resumed across the U.S. and many other parts of the world. But just because things appea…

Inflation Reduction Act Provision Aims To Further Spur Biosimilar Uptake With Temporary Add-On Payment In Medicare Part B

A temporary increase in payments from Medicare for physician-administered biosimilars is designed to further boost their uptake. The increase went into effect on October 3rd. It’s one of the lesser-known drug pricing provisions contained in the Inflati…

Broadly Neutralizing Monoclonal Antibodies For Covid-19 Treatment, Prevention, And Vaccine Design

Recently discovered monoclonal antibodies present an opportunity to create variant-independent treatments and preventions for Covid-19.

HHS Implements Inflationary Rebates For List Prices Of Medicare Part D (Outpatient) Drugs

The inflationary cap on list price growth will impact drug makers, which have already seen their net prices stagnate in recent years and even enter negative territory. It will also lower Medicare beneficiaries’ out-of-pocket spend and affect price nego…

Newly Approved ALS Drug Relyvrio To Face Its Next Challenge: Pricing And Reimbursement

There’s a swirl of controversy around FDA’s approval of Relyvrio, a new drug indicated for ALS (amyotrophic lateral sclerosis), often called Lou Gehrig’s Disease. But there are also pricing and reimbursement issues the drug will face as its sponsor, A…